Sonoma Pharmaceuticals (SNOA) Other Working Capital Changes (2010 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Other Working Capital Changes of $392000.0 in Q4 2025, up 1.55% quarter-over-quarter from $386000.0 in Q3 2025, and up 622122.22% on a YoY basis from N/an in Q4 2024.
Sonoma Pharmaceuticals (SNOA) Other Working Capital Changes (2010 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' Other Working Capital Changes history runs 16 years deep, the most recent figure standing at $392000.0 for Q4 2025.
- In Q4 2025, Other Working Capital Changes rose 622122.22% year-over-year to $392000.0; the TTM figure through Dec 2025 stood at $276000.0 (up 437995.24% YoY), while the FY2025 annual figure was $94.0, down 99.34% from the prior year.
- Other Working Capital Changes was $392000.0 for Q4 2025 at Sonoma Pharmaceuticals, up from $386000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.0 million in Q1 2023 to a low of -$1.0 million in Q1 2024.
- Historically, Other Working Capital Changes has averaged $61902.8 across 5 years, with a median of $5000.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes tumbled 2066.67% in 2024, then soared 3859900.0% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at $13996.0 in 2021, then jumped by 68.66% to $23605.0 in 2022, then plunged by 78.82% to $5000.0 in 2023, then sank by 98.74% to $63.0 in 2024, then soared by 622122.22% to $392000.0 in 2025.
- The last three Other Working Capital Changes figures came in at $392000.0 (Q4 2025), $386000.0 (Q3 2025), and $448000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 392,000.00 |
| Dec 31, 2025 | 392,000.00 |
| Sep 30, 2025 | 386,000.00 |
| Sep 30, 2025 | 386,000.00 |
| Jun 30, 2025 | 448,000.00 |
| Jun 30, 2025 | 448,000.00 |
| Mar 31, 2025 | -950,000.00 |
| Mar 31, 2025 | -950,000.00 |
| Dec 31, 2024 | 63.00 |
| Dec 31, 2024 | 63.00 |
| Sep 30, 2024 | 10.00 |
| Sep 30, 2024 | 10.00 |
| Jun 30, 2024 | -59,000.00 |
| Jun 30, 2024 | -59,000.00 |
| Mar 31, 2024 | -1.01 Mn |
| Mar 31, 2024 | -1.01 Mn |
| Dec 31, 2023 | 5,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |